SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950170-24-005586
Filing Date
2024-01-19
Accepted
2024-01-19 08:30:23
Documents
2
Period of Report
2024-01-12

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 5850
2 EX-24 cadl-ex24.htm EX-24 10824
  Complete submission text file 0000950170-24-005586.txt   18258
Mailing Address 117 KENDRICK STREET SUITE 450 NEEDHAM MA 02494
Business Address 117 KENDRICK STREET SUITE 450 NEEDHAM MA 02494 617-916-5445
Candel Therapeutics, Inc. (Issuer) CIK: 0001841387 (see all company filings)

IRS No.: 522214851 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address CANDEL THERAPEUTICS, INC. 117 KENDRICK ST., SUITE 450 NEEDHAM MA 02494
Business Address
Schoch Charles (Reporting) CIK: 0002007349 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40629 | Film No.: 24543805